Dr. Viviane Delghingaro Augusto

Biography

Viviane Delghingaro Augusto obtained her PhD in Functional Molecular Biology from the University of Campinas, Sao Paulo, Brazil. She further trained as an islet β-cell biologist under Professors Prentki in Montreal, Canada, and Nolan at ANU, Australia. Her postdoctoral work included key experiments on pancreatic islets through rodent models and pancreatic β-cell lines, resulting in the discovery of the islet β-cell glycerolipid/free fatty acid cycle, essential to the lipid amplification pathway for glucose-stimulated insulin secretion. This research has led to new targets for drug discovery in treating type 2 diabetes, including active patents from the Prentki laboratory. While in Canberra, she continued to refine her skills in pancreatic islet research and has significantly contributed to a major publication in Nature Genetics, which described pancreatic β-cell fragility in type 1 and type 2 diabetes mice models. Dr. Augusto has also engaged in a project funded by the NHMRC regarding the role of islet β-cell failure in the pathogenesis of non-alcoholic steatohepatitis. Her extensive training has equipped her with specialized skills in various aspects of islet biology.

Research Interests

Experience